Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics Inc (NQ: MRSN )

2.015 +0.185 (+10.11%)
Streaming Delayed Price Updated: 1:39 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,228,637
Open 1.800
Bid (Size) 2.010 (22)
Ask (Size) 2.020 (8)
Prev. Close 1.830
Today's Range 1.800 - 2.180
52wk Range 1.065 - 6.280
Shares Outstanding 71,761,525
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024
MRSN stock results show that Mersana Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-11.23%
-11.23%
1 Month
+38.97%
+38.97%
3 Month
+8.33%
+8.33%
6 Month
-52.25%
-52.25%
1 Year
+59.92%
+59.92%

More News

Read More
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
Via Benzinga
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
What To Know About Citigroup's Upgrade of Mersana Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
Why Mersana Therapeutics Stock Is Plunging Today?
Via Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
Via InvestorPlace
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
Via PressReach
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
How To Invest In The Healthcare Sector
Via Talk Markets
Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
Via Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
Via Benzinga
Dow Jumps 100 Points; US GDP Rises 2.4% In Q2
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.